SCHEMBL4905482

SCHEMBL4905482

CCN(c1ccc(-c2ccc(C)cc2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.51
TP53 P04637 1/20 0.51
ALDH1A1 P00352 3/20 0.48
TSHR P16473 2/20 0.48
LMNA P02545 1/20 0.46
ESR1 P03372 2/20 0.46
HSD17B10 Q99714 2/20 0.46
PKM P14618 2/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
HCRTR2 O43614 3/20 0.46
KEAP1 Q14145 1/20 0.45
NFE2L2 Q16236 1/20 0.45
GAA P10253 1/20 0.45
ATM Q13315 1/20 0.45
CYP2C9 P11712 1/20 0.44
PTGES O14684 1/20 0.43
ALOX5 P09917 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906761 0.93 ALDH1A1 (0.48) NPSR1TP53ALDH1A1TSHRLMNA
SCHEMBL4902995 0.92 HCRTR2 (0.47) NPSR1TP53ALDH1A1TSHRLMNA
SCHEMBL4898279 0.91 MAPT (0.51) TP53ALDH1A1TSHRLMNAESR1
SCHEMBL4899320 0.91 ALDH1A1 (0.52) NPSR1TP53ALDH1A1TSHRLMNA
SCHEMBL4904034 0.91 LMNA (0.50) NPSR1TP53ALDH1A1TSHRLMNA
SCHEMBL4908535 0.89 LMNA (0.54) NPSR1TP53ALDH1A1TSHRLMNA
SCHEMBL4900672 0.89 HDAC8 (0.51) NPSR1TP53ALDH1A1TSHRLMNA
SCHEMBL4905146 0.89 ALDH1A1 (0.50) NPSR1TP53ALDH1A1TSHRLMNA
SCHEMBL4909029 0.89 ALDH1A1 (0.47) NPSR1TP53ALDH1A1TSHRLMNA
SCHEMBL4902733 0.88 ESR1 (0.60) NPSR1ALDH1A1TSHRLMNAESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD NPSR1 735/4885TP53 3421/4885ALDH1A1 2956/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD NPSR1 735/4885TP53 3421/4885ALDH1A1 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.